Hap Trading, LLC Ironwood Pharmaceuticals Inc Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $234,695 - $301,473	-21,611 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $257,603 - $300,825	21,611 New	21,611 $282,000
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $150,890 - $198,467	-15,397 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$8.27 - $12.73 $81,575 - $125,568	-9,864 Reduced 39.05%	15,397 $208,000
Q4 2018 Feb 12, 2019	BUY	$7.8 - $16.13 $197,035 - $407,459	25,261 New	25,261 $262,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $663M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.